Mesenchymal stem cell therapy and acute graft-versus-host disease: a review
- PMID: 24903975
- PMCID: PMC4186969
- DOI: 10.1007/s13577-014-0095-x
Mesenchymal stem cell therapy and acute graft-versus-host disease: a review
Abstract
Mesenchymal stem cells (MSCs) are being widely studied as potential cell therapy agents due to their immunomodulatory properties, which have been established by in vitro studies and in several clinical trials. Within this context, mesenchymal stem cell therapy appears to hold substantial promise, particularly in the treatment of conditions involving autoimmune and inflammatory components. Nevertheless, many research findings are still contradictory, mostly due to difficulties in characterization of the effects of MSCs in vivo. The purpose of this review is to report the mechanisms underlying mesenchymal stem cell therapy for acute graft-versus-host disease, particularly with respect to immunomodulation, migration, and homing, as well as report clinical applications described in the literature.
References
-
- Morrison SJ, Shah NM, Anderson DJ. Regulatory mechanisms in stem cell biology. Cell. 1997;88(3):287–298. - PubMed
-
- Lemischka IR. Stem cell biology: a view toward the future. Ann N Y Acad Sci. 2005;1044:132–138. - PubMed
-
- Vogel G. Can old cells learn new tricks? Science. 2000;287(5457):1418–1419. - PubMed
-
- Chiu CP, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, et al. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells. 1996;14(2):239–248. - PubMed
-
- Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells. 2001;19(3):193–204. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
